Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/17/1998 | WO1998039034A3 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
12/17/1998 | WO1998037093A3 Compounds for immunotherapy of prostate cancer and methods for their use |
12/17/1998 | WO1998033919A3 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
12/17/1998 | DE19725368A1 New cyclic peptides inhibit ligand binding to integrins |
12/17/1998 | DE19725014A1 Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten Aprotinin variants with improved properties and Bikunine of aprotinin |
12/17/1998 | CA2295991A1 Human tumor necrosis factor receptor tr9 |
12/17/1998 | CA2295982A1 Human l105 proteins and polynucleotides encoding same |
12/17/1998 | CA2295980A1 Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence |
12/17/1998 | CA2295013A1 Controlled release pharmaceutical preparation with ace inhibitor as active agent |
12/17/1998 | CA2294526A1 86 human secreted proteins |
12/17/1998 | CA2294523A1 Method for preventing hiv-1 infection of cd4+ cells |
12/17/1998 | CA2293828A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
12/17/1998 | CA2293825A1 Secreted proteins and polynucleotides encoding them |
12/17/1998 | CA2293733A1 Mycardium-and skeletal muscle-specific nucleic acid, its preparation and use |
12/17/1998 | CA2293666A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same |
12/17/1998 | CA2293499A1 Compositions useful as fibrin sealants |
12/17/1998 | CA2293492A1 Cns neuroregenerative compositions and methods of use |
12/17/1998 | CA2293439A1 Ganglioside immunostimulating complexes and uses thereof |
12/17/1998 | CA2293363A1 Secreted proteins and polynucleotides encoding them |
12/17/1998 | CA2293350A1 Inhibition of the src kinase family pathway as a method of treating hbv infection and hepatocellular carcinoma |
12/17/1998 | CA2293302A1 Use of factor xiiia inhibitors to treat atherosclerosis |
12/17/1998 | CA2293250A1 Human phosphatidylinositol transfer protein gamma |
12/17/1998 | CA2293248A1 Human protein phosphatase ii-c-like protein |
12/17/1998 | CA2292611A1 Estrogen receptor ligands |
12/17/1998 | CA2292339A1 Smad6 and uses thereof |
12/17/1998 | CA2291645A1 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
12/17/1998 | CA2291338A1 Composition and method to prevent graft rejection and other counter-adaptive t lymphocyte mediated immune responses |
12/17/1998 | CA2289471A1 A novel method of detecting and treating cancer |
12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies |
12/16/1998 | EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML) |
12/16/1998 | EP0884387A2 Human 7-transmembrane receptor HLWAR77 |
12/16/1998 | EP0884386A1 Sodium channel receptor |
12/16/1998 | EP0884385A1 Intracellular modulators of apoptopic cell death pathways |
12/16/1998 | EP0884327A1 Dendritic lysine-based polypeptides for targeted drug delivery |
12/16/1998 | EP0884326A2 Antithrombitic compound |
12/16/1998 | EP0884325A1 Thrombin inhibitors containing a peptidyl heterocycle |
12/16/1998 | EP0884054A2 Fixed-dose association of an angiotensin-converting enzyme inhibitor and of a calcium channel antagonist for the treatment of cardiovascular illnesses |
12/16/1998 | EP0884053A1 Stable insulin formulations |
12/16/1998 | EP0884052A1 Cartilage/bone inducing materials for reparation |
12/16/1998 | EP0883993A1 Antiviral materials |
12/16/1998 | EP0883692A1 Methods for producing and analyzing biopolymer ladders |
12/16/1998 | EP0883688A1 Adapter molecules for targeting viral particles to cells |
12/16/1998 | EP0883687A2 C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses |
12/16/1998 | EP0883685A1 Method for obtaining microorganisms capable of producing antitumor molecules |
12/16/1998 | EP0883684A1 Method of purifying thrombin-like protease enzymes obtained from snake venom |
12/16/1998 | EP0883629A1 Oligopeptides for drug delivery |
12/16/1998 | EP0883625A1 Novel platelet activation protein |
12/16/1998 | EP0883406A1 Use of il-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular |
12/16/1998 | EP0883404A1 Combination therapy for osteoporosis |
12/16/1998 | EP0883344A1 Therapeutic molecules generated by trans-splicing |
12/16/1998 | EP0883343A1 Method for treating ischemic tissue |
12/16/1998 | EP0854726B1 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
12/16/1998 | EP0715618B1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
12/16/1998 | EP0695190A4 Regulator regions of g proteins |
12/16/1998 | EP0671942B1 Pharmaceutical preparation comprising a beta-lactam antibiotic degrading compound, and use thereof |
12/16/1998 | EP0669934B1 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
12/16/1998 | EP0610447B1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
12/16/1998 | CN1202200A Fas ligang fusion protein |
12/16/1998 | CN1202175A Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
12/16/1998 | CN1202174A Peptide derivatives |
12/16/1998 | CN1202161A Macrocyclic compounds as metalloprotease inhibitors |
12/16/1998 | CN1202114A Aqueous prolonged release formulation |
12/16/1998 | CN1202113A Pharmaceutical combination preparations containing erythropoietin and iron preparation |
12/16/1998 | CN1202112A Composition for improving pancreatic function |
12/16/1998 | CN1202104A Methods and compositions for stimulating neurite growth |
12/16/1998 | CN1041170C Bromelin decrustation preparation and its preparing method |
12/15/1998 | US5849991 Mice homozygous for an inactivated α 1,3-galactosyl transferase gene |
12/15/1998 | US5849918 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
12/15/1998 | US5849908 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
12/15/1998 | US5849904 Isolated nucleic acid molecules which hybridize to polysialyl transferases |
12/15/1998 | US5849903 Antisense oligonucleotides for IL-8 and IL-8 receptor |
12/15/1998 | US5849899 Human tumor suppressor |
12/15/1998 | US5849898 CD40 coding sequences |
12/15/1998 | US5849897 Nucleic acid molecule encoding ciliary neurotrophic factor receptor |
12/15/1998 | US5849896 α-subunit of the Mac-1 leukocyte adhesion receptor |
12/15/1998 | US5849895 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
12/15/1998 | US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics |
12/15/1998 | US5849886 Extraction of myelin basic protein |
12/15/1998 | US5849883 Method for purifying granulocyte colony stimulating factor |
12/15/1998 | US5849881 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
12/15/1998 | US5849880 Bone morphogenetic protein (BMP)--6 |
12/15/1998 | US5849877 Antigen-binding sites of antibody molecules specific for cancer antigens |
12/15/1998 | US5849876 Hybridomas producing monoclonal antibodies to new mucin epitopes |
12/15/1998 | US5849875 Human tissue factor inhibitor |
12/15/1998 | US5849873 Macrophage-derived inflammatory mediator (MIP-1 α and MIP-1 β) |
12/15/1998 | US5849869 Delta fragments and derivatives and methods based thereon |
12/15/1998 | US5849866 Peptidase inhibitors |
12/15/1998 | US5849865 Peptides for altering bone resorption, angiogenesis and restenosis |
12/15/1998 | US5849863 Cytolytic bradykinin antagonists |
12/15/1998 | US5849860 Polyethylene-protein conjugates |
12/15/1998 | US5849803 Method of treating erectile dysfunction with nitroglycerine |
12/15/1998 | US5849761 Peripherally active anti-hyperalgesic opiates |
12/15/1998 | US5849742 Compounds for the treament of disorders related to vasculogenesis and/or angiogenesis |
12/15/1998 | US5849727 Compositions and methods for altering the biodistribution of biological agents |
12/15/1998 | US5849719 Method for treating allergic lung disease |
12/15/1998 | US5849713 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
12/15/1998 | US5849711 Cathepsin and methods and compositions for inhibition thereof |
12/15/1998 | US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
12/15/1998 | US5849708 Promotion of eating behavior |
12/15/1998 | US5849706 Method of treating retained asthma pulmonary secretions |